Jul 15 2021
Learn how professor Michel Lisanti and collaborators integrated Inovotion’s technology into
their study to provide evidence that elevated ATP production by mitochondrial ATP synthase is a
new therapeutic target for cancer treatments, particularly for preventing tumor
progression. https://www.nature.com/articles/s41418-021-00788-x#Abs1
If you too are interested in optimizing your preclinical drug discovery with our powerful
in vivo technology platform, please contact us for a free estimate! www.inovotion/contact.com
If you wish to discover more example of Inovotion’s client publications in the best peer
reviewed journals please follow the link : https://www.inovotion.com/publications/publications
Apr 5-10
2024
Come and join us at AACR – April 5-10th in San Diego !
Inovotion will be at AACR – April 5 – 10th in San Diego ! Join us at Booth 552 at the hashtag#AACR24 ANNUAL MEETING 2024 April 5-10 in San Diego, California!! This is the focal […]
Mar 18-20
2024
Come and join us at BIO-EUROPE Spring – March 18-20th in Barcelona !
Inovotion will be at BIO-EUROPE Spring – March 18-20th in Barcelona ! Connect with the right partners at Europe’s largest partnering event. Sales Director Arnaud Peyronnier will join leading biotech and pharma executives to discuss […]
Feb 26-28
2024
Come and join us at ESMO-TAT, Feb 26-28 2024!!
INOVOTION will be present at the ESMO – European Society for Medical Oncology Targeted Anticancer Therapies Congress 2024 in Paris– February 26-28 in Paris! ESMO-TAT offers participants a glimpse into the future of anticancer therapies, […]
